Summary
Elevance Health, Inc. (ELV), formerly Anthem, Inc., issued an 8-K filing on March 2, 2021, primarily to disclose information regarding its upcoming Investor Day conference scheduled for March 3, 2021. During this event, the company intends to reaffirm its previously issued full-year 2021 financial guidance. Notably, this guidance does not incorporate the financial impact of the pending acquisition of the Puerto Rico-based subsidiaries of InnovaCare Health, L.P., which is expected to close by the end of the second quarter of 2021, with the exception of earnings per share metrics. The filing also serves as a reminder that conference materials will be made available on the company's investor relations website, with a replay also to be provided. Investors should be aware that the information furnished in this Item 7.01 is considered non-public and is not "filed" under Section 18 of the Securities Exchange Act of 1934. The document also includes standard forward-looking statements and a comprehensive list of risk factors that could materially impact the company's future performance.
Key Highlights
- 1Company will host its virtual Investor Day on March 3, 2021, to reaffirm full-year 2021 guidance.
- 2Full-year 2021 guidance does not include the financial impact of the InnovaCare Health acquisition, except for EPS metrics.
- 3The acquisition of InnovaCare Health's Puerto Rico subsidiaries is expected to close by the end of Q2 2021.
- 4Conference materials and a replay of the webcast will be available on the Elevance Health investor relations website.
- 5Information furnished in Item 7.01 is not considered 'filed' for the purposes of Section 18 of the Securities Exchange Act.
- 6The filing includes extensive forward-looking statements and risk factors relevant to investors.